In the modern era, individuals face various health challenges due to congenital conditions and lifestyle habits that can lead to malfunctioning or failure of internal organs. While medications can support organ function, they are not a permanent solution and come with long development times, high costs, and potential side effects. As organ failure, particularly kidney failure, continues to rise, the need for effective treatments, such as organ transplantation, becomes more critical. However, the limited availability of donors, the high genetic rejection rates, and the time-consuming nature of organ transplantation pose significant challenges. To address these issues, regenerative medicine and 3D bioprinting have emerged as promising solutions. This paper explores the cultivation and synthesis of cells for use in organ printing, focusing on the somatic nuclear transfer (SCNT) method, which offers advantages over traditional cell culture techniques. Unlike conventional methods, SCNT enables limitless cultivation of target cells, reduces immune rejection, and increases cell viability and rheological properties. This paper also discusses the SCNT process and the preparation of bio-inks for 3D organ printing, aiming to provide a viable alternative to organ transplantation.